# BioEclipse Therapeutics, Inc. — Form D/A

BioEclipse Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2019-10-10. The offering totals $11.8M, of which $10.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-10-10
- Form: D/A
- Accession: 0001780708-19-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $11.8M
- Amount sold: $10.1M
- Remaining: $1.6M
- Investors: 13
- Date of first sale: 2019-06-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-342724

## Issuer

- Name: BioEclipse Therapeutics, Inc.
- CIK: 0001780708
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 329 OYSTER POINT BLVD., 3RD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 408.809.1030

## Officers, directors & promoters (11)

| Name | Role | Location |
| --- | --- | --- |
| Elona Baum | Director | San Francisco, CA |
| Mark Frohlich | Director | Houston, TX |
| Biao He | Director | San Francisco, CA |
| Pamela Reilly Contag | Director | South San Francisco, CA |
| Gregory Schiffman | Director | Vancouver, WA |
| Catherine Sohn | Director | South San Francisco, CA |
| Benjamin Carter | Executive Officer | Dallas, TX |
| Pamela Reilly Contag | Executive Officer | South San Francisco, CA |
| Stephen Thau | Executive Officer | South San Francisco, CA |
| Pamela Contag | Director | South San Francisco, CA |
| Pamela Contag | Executive Officer | South San Francisco, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-06-25](https://search.stillhousedata.com/formd/0001780708-19-000003) | D | $9.1M | $7.8M |

## More

- [CIK 1780708 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1780708&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001780708-19-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.